FDA Warning Letters & 483 Inspections API
Pricing
from $150.00 / 1,000 compliance actions
FDA Warning Letters & 483 Inspections API
Joined feed of FDA Warning Letters + Form 483 inspection observations — facility-level severity-scored via FEI join. Pharma QA/QC, CMO/CDMO supplier risk, FDA defense counsel. The compliance-grade feed competitors that ship raw HTML scrapes can't match.
Pricing
from $150.00 / 1,000 compliance actions
Rating
0.0
(0)
Developer
NexGenData
Maintained by CommunityActor stats
0
Bookmarked
2
Total users
1
Monthly active users
5 days ago
Last modified
Categories
Share
📋 FDA Warning Letters + 483 Inspection Observations Tracker
The joined regulatory feed pharma compliance teams actually need. Every Warning Letter and Form 483 the FDA has issued in the last 5 years, mapped to the same facility via FDA Establishment Identifier (FEI), with a per-facility severity score derived from prior actions. Competing Apify actors ship raw HTML scrapes of a single Warning Letters page; this actor ships the joined CMO/CDMO supplier-risk feed that Verisk SteriQual and 3E sell at five figures a year.
The differentiator is the join — match Warning Letters on Pfizer's New Jersey plant to the four Form 483s the same plant has received in the last 18 months, and you get a "recurring" severity tag that drives supplier-risk decisions. Raw HTML scrapers can't do this because they only see one side of FDA's enforcement universe.
🧠 What you get
| Field | Notes |
|---|---|
type | warning_letter or form_483 |
date | Letter issue date or Form 483 issuance date (ISO-8601) |
manufacturer / facility | Company Name as published by the FDA |
fei_number | FDA Establishment Identifier — canonical facility join key |
state, country | From the 483 FOIA index (Warning Letters feed has implicit US default) |
product_type | drug / device / food / biologic / tobacco / veterinary / any — inferred from FDA Issuing Office (Warning Letters) or Establishment Type (Form 483s) |
issuing_office | Full FDA office string for Warning Letters (e.g. "Center for Drug Evaluation and Research (CDER)") |
subject / citation_summary | Subject line of the Warning Letter, or Form 483 — <establishment-type> inspection |
citations[] | List of 21 CFR cites parsed from the Warning Letter HTML (e.g. 21 CFR 211.113, 21 CFR 820.30(a)) — Warning Letters only, when the letter URL is resolvable |
fdc_act_citations[] | FD&C Act section cites (e.g. Section 501(a)(2)(B)) |
response_deadline_15_working_days | Boolean — whether the letter requires the standard 15-working-day response |
fda_division | The specific FDA division issuing the letter, when parseable from the HTML |
response_letter_received / closeout_letter_issued | Booleans from the Warning Letters feed |
full_text_url | Direct link to the FDA's published letter page (or FOIA index for 483s) |
establishment_type | For Form 483s — e.g. "Outsourcing Facility", "Producer of Sterile Drug Products" |
facility_severity_score | {score, label, prior_warning_letters, prior_form_483s} — clean (0 priors), single-prior (1), recurring (2-3), systemic (4+) |
🎯 Use cases
- Pharma QA/QC director — Daily monitoring of CDER Warning Letters against current finished-pharmaceutical CMOs; the severity score surfaces any contractor with a recurring
21 CFR 211.xposture before audit week. - CMO/CDMO supplier risk team — Cross-reference every active supplier's FEI against the joined feed; flag any facility with
severity_label="recurring"or"systemic"for re-qualification or fallback-sourcing. - FDA defense counsel — Pull all Warning Letters + 483s for a client facility, sorted by date, in one CSV — replaces the multi-tab spreadsheet that junior associates spend a day building per matter.
- Investment due diligence — Pre-IPO/M&A: scan the target's manufacturing footprint against the feed;
systemicseverity is a Section 8 closing condition issue. - Plaintiff law / mass tort intake — Tie individual product complaints (FAERS / MAUDE) to the issuing facility's regulatory posture for proximate-cause arguments.
📊 Sample input
{"manufacturer_name": "","product_type": "drug","days_back": 180,"severity_filter": "both","max_records": 50}
📊 Sample output
{"type": "warning_letter","date": "2026-04-07","posted_date": "2026-04-28","manufacturer": "Lexia LLC","facility": "Lexia LLC","state": null,"country": null,"fei_number": null,"product_type": "drug","issuing_office": "Center for Drug Evaluation and Research (CDER)","subject": "CGMP/Finished Pharmaceuticals/Adulterated","citation_summary": "CGMP/Finished Pharmaceuticals/Adulterated","citations": ["21 CFR 211.22", "21 CFR 211.100", "21 CFR 211.113"],"fdc_act_citations": ["section 501(a)(2)(B) of the FD&C Act"],"response_deadline_15_working_days": true,"fda_division": "Center for Drug Evaluation and Research (CDER)","response_letter_received": false,"closeout_letter_issued": false,"full_text_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/lexia-llc-...","facility_severity_score": {"score": 2,"label": "recurring","prior_warning_letters": 0,"prior_form_483s": 2},"source": "FDA Warning Letters"}
And a Form 483 record on the same facility:
{"type": "form_483","date": "2026-04-17","publish_date": "2026-05-27","manufacturer": "BPI Labs, LLC","facility": "BPI Labs, LLC","state": "Florida","country": "USA","fei_number": "3015156709","product_type": "drug","establishment_type": "Outsourcing Facility","record_type": "483","observation_count": null,"severity": "single-prior","citation_summary": "Form 483 — Outsourcing Facility inspection","full_text_url": "https://www.fda.gov/about-fda/office-regulatory-affairs/ora-foia-electronic-reading-room","facility_severity_score": {"score": 1,"label": "single-prior","prior_warning_letters": 1,"prior_form_483s": 0},"source": "FDA OII FOIA Electronic Reading Room (Form 483 index)"}
🚀 How to use
Run the actor from the Apify console, or programmatically:
from apify_client import ApifyClientclient = ApifyClient("YOUR_APIFY_TOKEN")run = client.actor("nexgendata/fda-warning-letters-483-inspections").call(run_input={"manufacturer_name": "Intas","product_type": "drug","days_back": 365,"severity_filter": "both","max_records": 100,})for item in client.dataset(run["defaultDatasetId"]).iterate_items():print(item["date"], item["type"], item["manufacturer"],item["facility_severity_score"]["label"])
cURL:
curl -X POST "https://api.apify.com/v2/acts/nexgendata~fda-warning-letters-483-inspections/runs?token=YOUR_APIFY_TOKEN" \-H "Content-Type: application/json" \-d '{"product_type":"drug","days_back":180,"max_records":50}'
⚖️ Compliance & data sources
All sources are published by the U.S. Food and Drug Administration under federal public-disclosure mandate (Federal Food, Drug, and Cosmetic Act § 705, 21 U.S.C. § 375) and are explicitly machine-readable via the XLSX export endpoints:
- Warning Letters:
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters/datatables-data— covers ~1,000 letters, ~5-year rolling window. - Form 483 Inspection Observation Index:
fda.gov/about-fda/office-regulatory-affairs/ora-foia-electronic-reading-room/download— OII FOIA Electronic Reading Room export, ~2,000 records, covering 483s + EIRs + closeout reports.
All HTTP requests are sent with the polite-bot User-Agent NexGenData FDA Warning Letters Actor hello@thenextgennexus.com. No anti-bot measures encountered. No FDA rate limits documented for these XLSX endpoints. The actor downloads each XLSX once per run (no per-record requests against FDA).
Future enhancements (paid add-ons under consideration): OCR of the underlying Form 483 PDFs to extract per-observation numbers (currently the FOIA index publishes the count of inspections but not the per-observation cite count from each 483 PDF), HTML enrichment of older Warning Letters whose URLs aren't on the recent-letters HTML index, and a Schedule-A export of the facility severity index alone (for supplier-onboarding KYC use).
🔗 Related Actors — NexGenData FDA / Healthcare Cluster
| Actor | What it does |
|---|---|
| ⚠️ FDA Recall Monitor | Drug + device safety alerts (recalls, withdrawals) — pairs with this actor for full FDA post-market surveillance |
| Federal Register Rules Scraper | Daily federal-register rule publications across all agencies — catches FDA proposed-rules that drive future Warning Letter citations |
| NIH Reporter Grants Scraper | Federal biomedical research funding — counterpart to FDA enforcement for the full healthcare-funding-and-enforcement picture |
| ⚕️ Doctor Directory Lead Finder | NPI-registry-backed physician lookups — useful for the pharma-payment + adverse-event analyst stack |
🏷️ About NexGenData
NexGenData publishes the deepest set of public-record data actors on Apify — SEC EDGAR forms (NPORT-P, 8-K, Form 4, Form D, 13F, 13D/G, ADV), CISA KEV + EPSS, DOL Form 5500, FDA Warning Letters + 483s + Recalls, FDA Adverse Events (FAERS+MAUDE), FINRA BrokerCheck, EUIPO trademarks, WIPO Patentscope, and more — all priced as pay-per-event so you only pay for the data you actually pull. Visit apify.com/nexgendata for the full catalog.